Konner JA - Search Results

1

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.

Chiang S, Vasudevaraja V, Serrano J, Stewart CJR, Oliva E, Momeni-Boroujeni A, Jungbluth AA, Da Cruz Paula A, da Silva EM, Weigelt B, Park KJ, Soslow RA, Murali R, Ellenson LH, Benayed R, Ladanyi M, Abu-Rustum NR, Dickson MA, Cohen S, Aghajanian C, Hensley ML, Lee CH, Snuderl M, Konner JA. Chiang S, et al. Among authors: konner ja. Mod Pathol. 2022 Jan;35(1):117-127. doi: 10.1038/s41379-021-00922-7. Epub 2021 Sep 24. Mod Pathol. 2022. PMID: 34561551 Free PMC article.

2

Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.

Coleman RL, Lorusso D, Oaknin A, Cecere SC, Denys H, Colombo N, van Gorp T, Konner JA, Romeo Marin M, Harter P, Murphy C, Wang Y, Esteves B, Method M, Matulonis U. Coleman RL, et al. Among authors: konner ja. Int J Gynecol Cancer. 2024 Aug 5;34(8):1119-1125. doi: 10.1136/ijgc-2024-005401. Int J Gynecol Cancer. 2024. PMID: 38858103 Free PMC article. Clinical Trial.

3

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Diefenbach CS, et al. Gynecol Oncol. 2007 Feb;104(2):435-42. doi: 10.1016/j.ygyno.2006.08.028. Epub 2006 Oct 4. Gynecol Oncol. 2007. PMID: 17023034

4

Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study.

Sovak MA, Dupont J, Hensley ML, Ishill N, Gerst S, Abu-Rustum N, Anderson S, Barakat R, Konner J, Poyner E, Sabbatini P, Spriggs DR, Aghajanian C. Sovak MA, et al. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):197-203. doi: 10.1111/j.1525-1438.2006.00746.x. Int J Gynecol Cancer. 2007. PMID: 17291253

5

Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy.

Sabbatini P, Mooney D, Iasonos A, Thaler H, Aghajanian C, Hensley M, Konner J, Spriggs D, Abu-Rustum NR, Dupont J. Sabbatini P, et al. Int J Gynecol Cancer. 2007 May-Jun;17(3):589-94. doi: 10.1111/j.1525-1438.2007.00823.x. Epub 2007 Feb 9. Int J Gynecol Cancer. 2007. PMID: 17300679

6

Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.

Sabbatini PJ, Ragupathi G, Hood C, Aghajanian CA, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu Rustum N, Dansihefsky SJ, Livingston PO. Sabbatini PJ, et al. Clin Cancer Res. 2007 Jul 15;13(14):4170-7. doi: 10.1158/1078-0432.CCR-06-2949. Clin Cancer Res. 2007. PMID: 17634545

7

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

Levine D, Park K, Juretzka M, Esch J, Hensley M, Aghajanian C, Lewin S, Konner J, Derosa F, Spriggs D, Iasonos A, Sabbatini P. Levine D, et al. Cancer. 2007 Dec 1;110(11):2448-56. doi: 10.1002/cncr.23072. Cancer. 2007. PMID: 17918264 Free article. Clinical Trial.

8

Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.

Zivanovic O, Barakat RR, Sabbatini PJ, Brown CL, Konner JA, Aghajanian CA, Abu-Rustum NR, Levine DA. Zivanovic O, et al. Among authors: konner ja. Cancer. 2008 Jun 15;112(12):2690-7. doi: 10.1002/cncr.23485. Cancer. 2008. PMID: 18428210 Free article.

9

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.

Konner J, Schilder RJ, DeRosa FA, Gerst SR, Tew WP, Sabbatini PJ, Hensley ML, Spriggs DR, Aghajanian CA. Konner J, et al. Gynecol Oncol. 2008 Aug;110(2):140-5. doi: 10.1016/j.ygyno.2008.04.018. Epub 2008 Jun 13. Gynecol Oncol. 2008. PMID: 18554700 Clinical Trial.

10

A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.

Hensley ML, Larkin J, Fury M, Gerst S, Tai DF, Sabbatini P, Konner J, Orlando M, Goss TL, Aghajanian CA. Hensley ML, et al. Clin Cancer Res. 2008 Oct 1;14(19):6310-6. doi: 10.1158/1078-0432.CCR-08-0338. Clin Cancer Res. 2008. PMID: 18829514 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters